Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael J. Fox Foundation for Parkinson’s Research (MJFF), a non-profit organization dedicated to finding a cure for Parkinson’s disease (PD), today announced a research project to accelerate research on genetic risk factors associated with PD, specifically […]
Precision microbiome science company, Microba Life Sciences, will work with Anatara Life Sciences (ASX:ANR) to complete microbiome analysis for a much-needed therapeutic treatment for sufferers of IBS-D. Anatara have commenced recruitment for a phase 1/2 clinical trial of their Gastrointestinal Re-Programming complementary medicine (GaRP) to address an unmet clinical need for IBS-D. Microba will apply […]
Precision microbiome science company, Microba Life Sciences, has appointed three respected key opinion leaders in Inflammatory Bowel Disease (IBD) to their IBD Advisory Panel to translate research into clinical outcomes for IBD sufferers. Professors from Mount Sinai Doctors in the United States, Professor Jean-Frederic Colombel, MD and University of Miami Health System, Professor Maria Teresa Abreu […]
UAE, among all the GCC countries after Saudi Arabia is showing tremendous growth rate with respect to the pharmaceutical industry. The entry of local and global companies in the market is leading to release of all the stagnant factors that have been the primary reason for the late arrival of the UAE market into the global pharmaceutical […]
